These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8186347)

  • 1. Famotidine increases plasma alcohol concentration in healthy subjects.
    Burnham DB; Miller D; Karlstadt R; Friedman CJ; Palmer RH
    Aliment Pharmacol Ther; 1994 Feb; 8(1):55-61. PubMed ID: 8186347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. H2-antagonists and alcohol. Do they interact?
    Gugler R
    Drug Saf; 1994 Apr; 10(4):271-80. PubMed ID: 7912509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged bedtime treatment with H2-receptor antagonists (ranitidine and famotidine) does not affect blood alcohol levels after ethanol ingestion in male patients with duodenal ulcer.
    Casini A; Pizzigallo AM; Mari F; Bertol E; Surrenti C
    Am J Gastroenterol; 1994 May; 89(5):745-9. PubMed ID: 8172150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of H2-receptor antagonists on ethanol metabolism in Japanese volunteers.
    Tanaka E; Nakamura K
    Br J Clin Pharmacol; 1988 Jul; 26(1):96-9. PubMed ID: 2904827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of gastric alcohol dehydrogenase activity by histamine H2-receptor antagonists has no influence on the pharmacokinetics of ethanol after a moderate dose.
    Mallat A; Roudot-Thoraval F; Bergmann JF; Trout H; Simonneau G; Dutreuil C; Blanc LE; Dhumeaux D; Delchier JC
    Br J Clin Pharmacol; 1994 Feb; 37(2):208-11. PubMed ID: 7910473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of increasing gastric pH with famotidine on the absorption and oral pharmacokinetics of the inotropic agent vesnarinone.
    Koneru B; Cowart DT; Noorisa M; Kisicki J; Bramer SL
    J Clin Pharmacol; 1998 May; 38(5):429-32. PubMed ID: 9602955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of effect of H2-receptor antagonists on the pharmacokinetics of alcohol consumed after food at lunchtime.
    Kendall MJ; Spannuth F; Walt RP; Gibson GJ; Hale KA; Braithwaite R; Langman MJ
    Br J Clin Pharmacol; 1994 Apr; 37(4):371-4. PubMed ID: 8018458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of famotidine on ciprofloxacin pharmacokinetics after single intravenous and oral doses in rats.
    al-Khamis KI; Jim LK; Bawazir SA; Ashour LF; el-Sayed N; el-Sayed YM
    J Clin Pharm Ther; 1994 Dec; 19(6):335-9. PubMed ID: 7876363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic and pharmacodynamic properties of lafutidine after postprandial oral administration in healthy subjects: comparison with famotidine.
    Ikawa K; Shimatani T; Hayato S; Morikawa N; Tazuma S
    Biol Pharm Bull; 2007 May; 30(5):1003-6. PubMed ID: 17473452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetics and pharmacodynamics of two morphologically homogenous forms of famotidine per os in Chinese healthy volunteers].
    Liu GL; Gao S; Wang SX; Shen WJ; Tan JQ
    Zhongguo Yao Li Xue Bao; 1993 May; 14(3):257-9. PubMed ID: 8237405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Famotidine pharmacokinetics following oral and intravenous administration in patients with liver disease: results of a preliminary study.
    Morgan MY; Stambuk D
    Postgrad Med J; 1986; 62 Suppl 2():29-37. PubMed ID: 2890149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of famotidine in normal subjects and in patients with chronic liver disease.
    Morgan MY; Stambuk D; Cottrell J; Mann SG
    Aliment Pharmacol Ther; 1990 Feb; 4(1):83-96. PubMed ID: 2104076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early and late effects of low-dose famotidine, ranitidine or placebo on pentagastrin-stimulated gastric acid secretion in man.
    Grimley CE; West JM; Loft DE; Cottrell J; Mann SG; Stauffer L; Nwokolo CU
    Aliment Pharmacol Ther; 1996 Oct; 10(5):743-7. PubMed ID: 8899082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of antacids and food on absorption of famotidine.
    Lin JH; Chremos AN; Kanovsky SM; Schwartz S; Yeh KC; Kann J
    Br J Clin Pharmacol; 1987 Oct; 24(4):551-3. PubMed ID: 2891370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of bioequivalence of a new fixed-dose combination of acarbose and metformin with the corresponding loose combination as well as the drug-drug interaction potential between both drugs in healthy adult male subjects.
    Kim S; Jang IJ; Shin D; Shin DS; Yoon S; Lim KS; Yu KS; Li J; Zhang H; Liu Y; Brendel E; Blode H; Wang Y
    J Clin Pharm Ther; 2014 Aug; 39(4):424-31. PubMed ID: 24806030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of famotidine on the pharmacokinetics of apixaban, an oral direct factor Xa inhibitor.
    Upreti VV; Song Y; Wang J; Byon W; Boyd RA; Pursley JM; Lacreta F; Frost CE
    Clin Pharmacol; 2013; 5():59-66. PubMed ID: 23637566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and pharmacodynamics of famotidine in children.
    James LP; Marshall JD; Heulitt MJ; Wells TG; Letzig L; Kearns GL
    J Clin Pharmacol; 1996 Jan; 36(1):48-54. PubMed ID: 8932543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of alcohol-induced hypoglycaemia by H2-receptor antagonists.
    Czyzyk A; Lao B; Szutowski M; Szczepanik Z; Muszyński J
    Arzneimittelforschung; 1997 Jun; 47(6):746-9. PubMed ID: 9239453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the acid suppression effects between low-dose esomeprazole and famotidine in healthy subjects.
    Kim HY; Hwang JG; Kim JW; Seong CH; Lee JH; Choi YS; Min HJ; Kim HS; Kim HY; Kim YK; Park MK
    Int J Clin Pharmacol Ther; 2023 Sep; 61(9):377-385. PubMed ID: 37382329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.